Global Drug, Anti-infective Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Drug, Anti-infective

• 1.1 Definition of Drug, Anti-infective
• 1.2 Drug, Anti-infective Segment by Type
  • 1.2.1 Global Drug, Anti-infective Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 OTC
  • 1.2.3 Rx Drugs
• 1.3 Drug, Anti-infective Segment by Applications
  • 1.3.1 Global Drug, Anti-infective Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Drugs Store
  • 1.3.4 Other
• 1.4 Global Drug, Anti-infective Overall Market
  • 1.4.1 Global Drug, Anti-infective Revenue (2014-2025)
  • 1.4.2 Global Drug, Anti-infective Production (2014-2025)
  • 1.4.3 North America Drug, Anti-infective Status and Prospect (2014-2025)
  • 1.4.4 Europe Drug, Anti-infective Status and Prospect (2014-2025)
  • 1.4.5 China Drug, Anti-infective Status and Prospect (2014-2025)
  • 1.4.6 Japan Drug, Anti-infective Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Drug, Anti-infective Status and Prospect (2014-2025)
  • 1.4.8 India Drug, Anti-infective Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Drug, Anti-infective
• 2.3 Manufacturing Process Analysis of Drug, Anti-infective
• 2.4 Industry Chain Structure of Drug, Anti-infective

3 Development and Manufacturing Plants Analysis of Drug, Anti-infective

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Drug, Anti-infective Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Drug, Anti-infective
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Drug, Anti-infective Production and Capacity Analysis
• 4.2 Drug, Anti-infective Revenue Analysis
• 4.3 Drug, Anti-infective Price Analysis
• 4.4 Market Concentration Degree

5 Drug, Anti-infective Regional Market Analysis

• 5.1 Drug, Anti-infective Production by Regions
  • 5.1.1 Global Drug, Anti-infective Production by Regions
  • 5.1.2 Global Drug, Anti-infective Revenue by Regions
• 5.2 Drug, Anti-infective Consumption by Regions
• 5.3 North America Drug, Anti-infective Market Analysis
  • 5.3.1 North America Drug, Anti-infective Production
  • 5.3.2 North America Drug, Anti-infective Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Drug, Anti-infective Import and Export
• 5.4 Europe Drug, Anti-infective Market Analysis
  • 5.4.1 Europe Drug, Anti-infective Production
  • 5.4.2 Europe Drug, Anti-infective Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Drug, Anti-infective Import and Export
• 5.5 China Drug, Anti-infective Market Analysis
  • 5.5.1 China Drug, Anti-infective Production
  • 5.5.2 China Drug, Anti-infective Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Drug, Anti-infective Import and Export
• 5.6 Japan Drug, Anti-infective Market Analysis
  • 5.6.1 Japan Drug, Anti-infective Production
  • 5.6.2 Japan Drug, Anti-infective Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Drug, Anti-infective Import and Export
• 5.7 Southeast Asia Drug, Anti-infective Market Analysis
  • 5.7.1 Southeast Asia Drug, Anti-infective Production
  • 5.7.2 Southeast Asia Drug, Anti-infective Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Drug, Anti-infective Import and Export
• 5.8 India Drug, Anti-infective Market Analysis
  • 5.8.1 India Drug, Anti-infective Production
  • 5.8.2 India Drug, Anti-infective Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Drug, Anti-infective Import and Export

6 Drug, Anti-infective Segment Market Analysis (by Type)

• 6.1 Global Drug, Anti-infective Production by Type
• 6.2 Global Drug, Anti-infective Revenue by Type
• 6.3 Drug, Anti-infective Price by Type

7 Drug, Anti-infective Segment Market Analysis (by Application)

• 7.1 Global Drug, Anti-infective Consumption by Application
• 7.2 Global Drug, Anti-infective Consumption Market Share by Application (2014-2019)

8 Drug, Anti-infective Major Manufacturers Analysis

• 8.1 GlaxoSmithKline
  • 8.1.1 GlaxoSmithKline Drug, Anti-infective Production Sites and Area Served
  • 8.1.2 GlaxoSmithKline Product Introduction, Application and Specification
  • 8.1.3 GlaxoSmithKline Drug, Anti-infective Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Merck
  • 8.2.1 Merck Drug, Anti-infective Production Sites and Area Served
  • 8.2.2 Merck Product Introduction, Application and Specification
  • 8.2.3 Merck Drug, Anti-infective Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Pfizer
  • 8.3.1 Pfizer Drug, Anti-infective Production Sites and Area Served
  • 8.3.2 Pfizer Product Introduction, Application and Specification
  • 8.3.3 Pfizer Drug, Anti-infective Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Novartis AG
  • 8.4.1 Novartis AG Drug, Anti-infective Production Sites and Area Served
  • 8.4.2 Novartis AG Product Introduction, Application and Specification
  • 8.4.3 Novartis AG Drug, Anti-infective Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Gilead Sciences
  • 8.5.1 Gilead Sciences Drug, Anti-infective Production Sites and Area Served
  • 8.5.2 Gilead Sciences Product Introduction, Application and Specification
  • 8.5.3 Gilead Sciences Drug, Anti-infective Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Abbott
  • 8.6.1 Abbott Drug, Anti-infective Production Sites and Area Served
  • 8.6.2 Abbott Product Introduction, Application and Specification
  • 8.6.3 Abbott Drug, Anti-infective Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Wyeth
  • 8.7.1 Wyeth Drug, Anti-infective Production Sites and Area Served
  • 8.7.2 Wyeth Product Introduction, Application and Specification
  • 8.7.3 Wyeth Drug, Anti-infective Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Sanofi-Aventis
  • 8.8.1 Sanofi-Aventis Drug, Anti-infective Production Sites and Area Served
  • 8.8.2 Sanofi-Aventis Product Introduction, Application and Specification
  • 8.8.3 Sanofi-Aventis Drug, Anti-infective Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Bristol-Myers Squibb
  • 8.9.1 Bristol-Myers Squibb Drug, Anti-infective Production Sites and Area Served
  • 8.9.2 Bristol-Myers Squibb Product Introduction, Application and Specification
  • 8.9.3 Bristol-Myers Squibb Drug, Anti-infective Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Johnson
  • 8.10.1 Johnson Drug, Anti-infective Production Sites and Area Served
  • 8.10.2 Johnson Product Introduction, Application and Specification
  • 8.10.3 Johnson Drug, Anti-infective Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Roche Pharma AG
• 8.12 Nanosphere
• 8.13 NanoViricides
• 8.14 Novabay Pharmaceuticals
• 8.15 Obetech
• 8.16 Optimer Pharmaceuticals
• 8.17 Basilea Pharmaceutica AG
• 8.18 Daiichi Sankyo
• 8.19 MerLion Pharma
• 8.20 Theravance

9 Development Trend of Analysis of Drug, Anti-infective Market

• 9.1 Global Drug, Anti-infective Market Trend Analysis
  • 9.1.1 Global Drug, Anti-infective Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Drug, Anti-infective Regional Market Trend
  • 9.2.1 North America Drug, Anti-infective Forecast 2019-2025
  • 9.2.2 Europe Drug, Anti-infective Forecast 2019-2025
  • 9.2.3 China Drug, Anti-infective Forecast 2019-2025
  • 9.2.4 Japan Drug, Anti-infective Forecast 2019-2025
  • 9.2.5 Southeast Asia Drug, Anti-infective Forecast 2019-2025
  • 9.2.6 India Drug, Anti-infective Forecast 2019-2025
• 9.3 Drug, Anti-infective Market Trend (Product Type)
• 9.4 Drug, Anti-infective Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Drug, Anti-infective Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List